Philips introduces the next generation of mammography for women, with the Philips MicroDose mammography system

November 5, 2012

 Melaka, Malaysia – In line with Breast Cancer Awareness month in October 2012, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) introduced the first Philips MicroDose Mammography System in ASEAN at the Putra Specialist Hospital Melaka on 31 October. The MicroDose is the first mammography system with an average 40 percent reduction in radiation dose.

 

The Future of Mammography with Philips MicroDose
MicroDose is the only FDA-cleared mammography system that uses X-ray photon-counting technology. Similar to light-emitting diode (LED) lighting which uses less wattage than traditional incandescent bulbs while providing high light output, the Philips MicroDose patented photon-counting detector utilizes less radiation while delivering excellent image quality. The patented photon counting detector is more efficient compared to standard detectors and therefore the x-ray power and the x-ray dose can be reduced.

 

Low dose mammography can even enhance the efficiency of screenings, by increasing the diagnostic confidence of clinicians while avoiding unnecessary radiation exposure for patients.

 

"Philips MicroDose Mammography addresses the challenge of volume faced by clinicians, who perform as many as 15 four-image examinations per hour. Yet speed should never compromise quality, and we wish to provide women with comfort and excellent image quality", says Suvendra Das, General Manager, Philips Healthcare Singapore and Malaysia.

 

He adds: "The key difference about Philips Healthcare is that we are people focused – we start with the needs of patients and their care providers, because understanding their experiences ensures that we create solutions that best meet their needs. The Philips MicroDose mammography system is an excellent example of this, focusing on the needs of patient comfort and relaxation and the constant strive of clinicians to provide safer diagnoses."

 

The Philips MicroDose received approval by the US Food and Drug Administration in May 2011. Philips MicroDose is currently available in 18 European countries, Australia, New Zealand and Japan.

 

As part of the Philips' global Breast Cancer Awareness campaign, Philips will be embarking on a Best Breast Cancer Screening Program with the National Cancer Society Malaysia (NCSM). 

"Philips is a company devoted to health and well-being, developing meaningful initiatives around the needs of consumers around the world, many of whom are women. It is this that makes our support for breast cancer awareness such a great fit for the business and we’re delighted to be building on our multi-year global strategy and commitment with the important message of early detection into this campaign," Suvendra further explains.

 

This campaign aims to raise awareness and educate communities about breast cancer screening and also aims to focus on prevention through lifestyle modifications and will involve underprivileged and/or inaccessible communities.

 

The programme calls upon NGOs and government hospitals to submit innovative ideas for breast cancer screening awareness among Malaysians. More details of this programme will be released in mid-November.

 

Continue lighting up the world
For many years, Philips Lighting has been supporting the cause by using the power and versatility of coloured LED light to illuminate global landmarks, highlighting the importance of early breast cancer detection.

 

This year in Malaysia, the National Science Museum is chosen to be illuminated in pink lights using Philips’ innovative and environmentally-friendly LED technology as part of the campaign’s landmark illumination activity each year.

For further information, please contact:

Name: Christina Celestine
Sector / department: Healthcare and Corporate Communications
E-mail: christina.celestine@philips.com
.

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6 billion and employs approximately 121,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

.